ClinConnect ClinConnect Logo
Search / Trial NCT06689319

Factors Linked to AI Literacy in University Students

Launched by NAGIHAN ACET · Nov 13, 2024

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

Artificial Intelligence Reading Habits Smartphone Addiction Internet Addiction

ClinConnect Summary

This clinical trial is studying how well university students understand artificial intelligence (AI) and what factors may influence their knowledge. Researchers want to find out if things like academic performance, reading habits, smartphone use, and internet habits impact how well students can understand and evaluate AI technologies. As AI becomes a bigger part of our lives, being knowledgeable about it is important. The study will involve students aged 18 to 35 from the Physiotherapy and Rehabilitation Department at Atılım University.

To take part in the study, participants need to be between 18 and 35 years old and willing to learn more about the study before deciding to join. Those who don’t fill out the questionnaires completely, are unable to read, or can’t cooperate will not be included. Participants can expect to answer questions that will help researchers measure their AI literacy and explore how it relates to their academic and personal habits. The findings may help improve teaching methods for understanding AI in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being between 18-35 years of age.
  • Willingness to participate after receiving detailed information about the study's purpose and methodology.
  • Exclusion Criteria:
  • Missing responses in questionnaires.
  • Illiteracy.
  • Inability to cooperate.

About Nagihan Acet

Nagihan Acet is a pioneering clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies. With a robust portfolio of clinical trials spanning various therapeutic areas, Nagihan Acet emphasizes rigorous scientific methodology and patient-centric approaches. The organization is committed to fostering collaboration with healthcare professionals, regulatory bodies, and research institutions to ensure the highest standards of safety, efficacy, and ethical conduct in all trial phases. By leveraging cutting-edge technologies and data analytics, Nagihan Acet aims to expedite the development of novel therapies and contribute to the global healthcare landscape.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported